Shaun Bagai
Vermogen: 357 053 $ op 30-06-2026
Vermogen: 357 053 $ op 30-06-2026
Shaun R.
Bagai currently works at RenovoRx, Inc., as President, CEO, Secretary & Director from 2014.
Mr. Bagai also formerly worked at HeartFlow, Inc., as Global Market Development from 2011 to 2014.
Mr. Bagai received his undergraduate degree from the University of California, Santa Barbara.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RENOVORX, INC. 0,81% | 15-04-2026 | 364.340 ( 0,81% ) | 357 053 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RENOVORX, INC. | Algemeen Directeur | 27-10-2014 |
| Bedrijven | Functie | Einde |
|---|---|---|
| HEARTFLOW, INC. | Corporate Officer/Principal | 01-01-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
HeartFlow, Inc.
HeartFlow, Inc. Packaged SoftwareTechnology Services Develops AI powered medical imaging platform that uses a patient’s coronary CT scan (CCTA) to build a personalized 3-D model of their heart and deliver a non-invasive solution for diagnosing & managing coronary artery disease | Technology Services |
RenovoRx, Inc.
RenovoRx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapies for the local treatment of solid tumors | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau